IMCD Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 5,237

Employees

  • Stock Symbol
  • IMCD

Stock Symbol

  • Investments
  • 111

  • Share Price
  • $111.43
  • (As of Friday Closing)

IMCD General Information

Description

IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.

Contact Information

Formerly Known As
Internatio, Internatio-Müller Chemical Distribution
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Wilhelminaplein 32
  • 3072 DE Rotterdam
  • Netherlands
+31 010
Primary Industry
Specialty Chemicals
Other Industries
Distributors/Wholesale
Other Commercial Products
Stock Exchange
AMS
Vertical(s)
Corporate Office
  • Wilhelminaplein 32
  • 3072 DE Rotterdam
  • Netherlands
+31 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IMCD Stock Performance

As of 20-Nov-2026, IMCD’s stock price is $111.43. Its current market cap is $6.58B with 59M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$111.43 $116.68 $78.88 - $122.74 $6.58B 59M 133K $4.54

IMCD Financials Summary

As of 30-Jun-2026, IMCD has a trailing 12-month revenue of $5.77B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 7,020,372 6,758,142 9,879,288 10,580,485
Revenue 5,766,877 5,390,599 5,115,733 4,807,274
EBITDA 617,164 562,940 631,374 609,752
Net Income 268,541 245,429 301,086 316,259
Total Assets 5,646,738 5,445,383 5,076,181 4,592,466
Total Debt 1,654,881 2,019,508 1,764,448 1,318,457
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IMCD Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IMCD‘s full profile, request access.

Request a free trial

IMCD Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets.
Specialty Chemicals
Rotterdam, Netherlands
5,237 As of 2026

Berchem, Belgium
 

Essen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IMCD Competitors (6)

One of IMCD’s 6 competitors is Azelis Group, a Formerly PE-Backed company based in Berchem, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Azelis Group Formerly PE-Backed Berchem, Belgium
Brenntag Formerly PE-Backed Essen, Germany
Brenntag UK Holding Corporation Leeds, United Kingdom
Univar Solutions Private Equity-Backed Downers Grove, IL
Parchem Fine and Specialty Chemicals Corporation New Rochelle, NY
To view IMCD’s complete competitors history, request access »

IMCD Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IMCD Investments & Acquisitions (111)

IMCD’s most recent deal was a Merger/Acquisition with Merit Solution. The deal was made on 29-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Merit Solution 29-Jun-2026 Merger/Acquisition Distributors/Wholesale
Willows Ingredients 19-Mar-2026 Merger/Acquisition Distributors/Wholesale
Dong Yang FT 15-Jan-2026 Merger/Acquisition Distributors/Wholesale
Tillmanns 09-Dec-2025 Merger/Acquisition Specialty Chemicals
Valuetree Ingredients 07-Aug-2025 Secondary Transaction - Private Distributors/Wholesale
You’re viewing 5 of 111 investments and acquisitions. Get the full list »

IMCD ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

11.06 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Traders & Distributors

Industry

of 158

Rank

Percentile

Trading and Distribution

Subindustry

of 158

Rank

Percentile

To view IMCD’s complete esg history, request access »

IMCD Exits (2)

IMCD’s most recent exit was on 12-Nov-2012 from Hatch Küttner. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Hatch Küttner 12-Nov-2012 Completed
  • 3 buyers
Nutri Granulations Merger/Acquisition Completed
To view IMCD’s complete exits history, request access »

IMCD Affiliates

Subsidiaries (40)

Name Industry Location Year Founded
O&3 Ripon, United Kingdom 2018
Apus Química San Bernardo, Chile 2016
Imcd Finance Rotterdam, Netherlands 2011
Cobapharma Barcelona, Spain 2011
Internatio Special Products Rotterdam, Netherlands 2010
You’re viewing 5 of 40 affiliates. Get the full list.  »

IMCD FAQs

  • When was IMCD founded?

    IMCD was founded in 1995.

  • Where is IMCD headquartered?

    IMCD is headquartered in Rotterdam, Netherlands.

  • What is the size of IMCD?

    IMCD has 5,237 total employees.

  • What industry is IMCD in?

    IMCD’s primary industry is Specialty Chemicals.

  • Is IMCD a private or public company?

    IMCD is a Public company.

  • What is IMCD’s stock symbol?

    The ticker symbol for IMCD is IMCD.

  • What is the current stock price of IMCD?

    As of 20-Nov-2026 the stock price of IMCD is $111.43.

  • What is the current market cap of IMCD?

    The current market capitalization of IMCD is $6.58B.

  • What is IMCD’s current revenue?

    The trailing twelve month revenue for IMCD is $5.77B.

  • Who are IMCD’s competitors?

    Azelis Group, Brenntag, Brenntag UK Holding, Univar Solutions, and Parchem Fine and Specialty Chemicals are some of the 6 competitors of IMCD.

  • What is IMCD’s annual earnings per share (EPS)?

    IMCD’s EPS for 12 months was $4.54.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process